Clinical Trial Update: Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial explored dose-response effects of Quillivant XR in children with ADHD and autism, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Seattle Children's Hospital | Conditions: ADHD, Autism | Phase 4 | Status: COMPLETED | Results posted: 2017-06-05